BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1912 related articles for article (PubMed ID: 30962574)

  • 21. Regulation of ferroptotic cancer cell death by GPX4.
    Yang WS; SriRamaratnam R; Welsch ME; Shimada K; Skouta R; Viswanathan VS; Cheah JH; Clemons PA; Shamji AF; Clish CB; Brown LM; Girotti AW; Cornish VW; Schreiber SL; Stockwell BR
    Cell; 2014 Jan; 156(1-2):317-331. PubMed ID: 24439385
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Luteolin exhibits synergistic therapeutic efficacy with erastin to induce ferroptosis in colon cancer cells through the HIC1-mediated inhibition of GPX4 expression.
    Zheng Y; Li L; Chen H; Zheng Y; Tan X; Zhang G; Jiang R; Yu H; Lin S; Wei Y; Wang Y; Zhang R; Liu Z; Wu J
    Free Radic Biol Med; 2023 Nov; 208():530-544. PubMed ID: 37717793
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Peroxidation of polyunsaturated fatty acids by lipoxygenases drives ferroptosis.
    Yang WS; Kim KJ; Gaschler MM; Patel M; Shchepinov MS; Stockwell BR
    Proc Natl Acad Sci U S A; 2016 Aug; 113(34):E4966-75. PubMed ID: 27506793
    [TBL] [Abstract][Full Text] [Related]  

  • 24. GPX4 at the Crossroads of Lipid Homeostasis and Ferroptosis.
    Forcina GC; Dixon SJ
    Proteomics; 2019 Sep; 19(18):e1800311. PubMed ID: 30888116
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lipid Peroxidation and GPX4 Inhibition Are Common Causes for Myofibroblast Differentiation and Ferroptosis.
    Gong Y; Wang N; Liu N; Dong H
    DNA Cell Biol; 2019 Jul; 38(7):725-733. PubMed ID: 31140862
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Non-enzymatic lipid peroxidation initiated by photodynamic therapy drives a distinct ferroptosis-like cell death pathway.
    Shui S; Zhao Z; Wang H; Conrad M; Liu G
    Redox Biol; 2021 Sep; 45():102056. PubMed ID: 34229160
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gα
    Tak J; Kim YS; Kim TH; Park GC; Hwang S; Kim SG
    Theranostics; 2022; 12(4):1570-1588. PubMed ID: 35198058
    [No Abstract]   [Full Text] [Related]  

  • 28. SIRT3 deficiency is resistant to autophagy-dependent ferroptosis by inhibiting the AMPK/mTOR pathway and promoting GPX4 levels.
    Han D; Jiang L; Gu X; Huang S; Pang J; Wu Y; Yin J; Wang J
    J Cell Physiol; 2020 Nov; 235(11):8839-8851. PubMed ID: 32329068
    [TBL] [Abstract][Full Text] [Related]  

  • 29. GPX4-Regulated Ferroptosis Mediates S100-Induced Experimental Autoimmune Hepatitis Associated with the Nrf2/HO-1 Signaling Pathway.
    Zhu L; Chen D; Zhu Y; Pan T; Xia D; Cai T; Lin H; Lin J; Jin X; Wu F; Yu S; Zhu K; Xu L; Chen Y
    Oxid Med Cell Longev; 2021; 2021():6551069. PubMed ID: 34966478
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glutathione peroxidase 4 inhibition induces ferroptosis and mTOR pathway suppression in thyroid cancer.
    Sekhar KR; Hanna DN; Cyr S; Baechle JJ; Kuravi S; Balusu R; Rathmell K; Baregamian N
    Sci Rep; 2022 Nov; 12(1):19396. PubMed ID: 36371529
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictive and prognostic impact of ferroptosis-related genes ACSL4 and GPX4 on breast cancer treated with neoadjuvant chemotherapy.
    Sha R; Xu Y; Yuan C; Sheng X; Wu Z; Peng J; Wang Y; Lin Y; Zhou L; Xu S; Zhang J; Yin W; Lu J
    EBioMedicine; 2021 Sep; 71():103560. PubMed ID: 34482070
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Solasonine promotes ferroptosis of hepatoma carcinoma cells via glutathione peroxidase 4-induced destruction of the glutathione redox system.
    Jin M; Shi C; Li T; Wu Y; Hu C; Huang G
    Biomed Pharmacother; 2020 Sep; 129():110282. PubMed ID: 32531676
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PHLDA2-mediated phosphatidic acid peroxidation triggers a distinct ferroptotic response during tumor suppression.
    Yang X; Wang Z; Samovich SN; Kapralov AA; Amoscato AA; Tyurin VA; Dar HH; Li Z; Duan S; Kon N; Chen D; Tycko B; Zhang Z; Jiang X; Bayir H; Stockwell BR; Kagan VE; Gu W
    Cell Metab; 2024 Apr; 36(4):762-777.e9. PubMed ID: 38309267
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MiR-15a-3p regulates ferroptosis via targeting glutathione peroxidase GPX4 in colorectal cancer.
    Liu L; Yao H; Zhou X; Chen J; Chen G; Shi X; Wu G; Zhou G; He S
    Mol Carcinog; 2022 Mar; 61(3):301-310. PubMed ID: 34727409
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SHARPIN promotes cell proliferation of cholangiocarcinoma and inhibits ferroptosis via p53/SLC7A11/GPX4 signaling.
    Zeng C; Lin J; Zhang K; Ou H; Shen K; Liu Q; Wei Z; Dong X; Zeng X; Zeng L; Wang W; Yao J
    Cancer Sci; 2022 Nov; 113(11):3766-3775. PubMed ID: 35968603
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Boosting the Ferroptotic Antitumor Efficacy via Site-Specific Amplification of Tailored Lipid Peroxidation.
    An Y; Zhu J; Liu F; Deng J; Meng X; Liu G; Wu H; Fan A; Wang Z; Zhao Y
    ACS Appl Mater Interfaces; 2019 Aug; 11(33):29655-29666. PubMed ID: 31359759
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low-density lipoprotein docosahexaenoic acid nanoparticles induce ferroptotic cell death in hepatocellular carcinoma.
    Ou W; Mulik RS; Anwar A; McDonald JG; He X; Corbin IR
    Free Radic Biol Med; 2017 Nov; 112():597-607. PubMed ID: 28893626
    [TBL] [Abstract][Full Text] [Related]  

  • 38. p53-mediated ferroptosis is required for 1-methyl-4-phenylpyridinium-induced senescence of PC12 cells.
    Li S; Wang M; Wang Y; Guo Y; Tao X; Wang X; Cao Y; Tian S; Li Q
    Toxicol In Vitro; 2021 Jun; 73():105146. PubMed ID: 33737050
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ferroptosis is involved in polymyxin B-induced acute kidney injury via activation of p53.
    Li H; Wang B; Wu S; Dong S; Jiang G; Huang Y; Tong X; Yu M
    Chem Biol Interact; 2023 Jun; 378():110479. PubMed ID: 37088170
    [TBL] [Abstract][Full Text] [Related]  

  • 40. FSP1 is a glutathione-independent ferroptosis suppressor.
    Doll S; Freitas FP; Shah R; Aldrovandi M; da Silva MC; Ingold I; Goya Grocin A; Xavier da Silva TN; Panzilius E; Scheel CH; Mourão A; Buday K; Sato M; Wanninger J; Vignane T; Mohana V; Rehberg M; Flatley A; Schepers A; Kurz A; White D; Sauer M; Sattler M; Tate EW; Schmitz W; Schulze A; O'Donnell V; Proneth B; Popowicz GM; Pratt DA; Angeli JPF; Conrad M
    Nature; 2019 Nov; 575(7784):693-698. PubMed ID: 31634899
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 96.